Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/21/2010CA2423351C Novel arylalkane-sulfonamides
12/21/2010CA2411981C Urokinase inhibitors
12/21/2010CA2408596C New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
12/21/2010CA2404594C Agent for prophylaxis and treatment of renal disease
12/21/2010CA2401778C Benzamides and related inhibitors of factor xa
12/21/2010CA2397981C Azacyclic compounds for use in the treatment of serotonin related diseases
12/21/2010CA2395100C Substituted sapogenins and their use
12/21/2010CA2378396C Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement
12/21/2010CA2371517C An improving agent for hypoalbuminaemia
12/21/2010CA2369895C High affinity inhibitors for target validation and uses thereof
12/21/2010CA2362858C Compositions and methods for their preparation from lepidium
12/21/2010CA2359246C Polyester packaging for nicotine containing product
12/21/2010CA2351836C Glycosphingolipid
12/21/2010CA2309326C Pharmaceutical compositions containing cyclodextrins and taxoids
12/21/2010CA2306748C Treatment of fibromyalgia and related disorders
12/21/2010CA2294924C Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
12/21/2010CA2267069C Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy
12/21/2010CA2260273C Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
12/21/2010CA2214406C Use of penciclovir for the treatment of human herpes-virus-8
12/21/2010CA2199821C Cloning and regulation of an endothelial cell protein c/activated protein c receptor
12/19/2010CA2670301A1 Inhibition of metastasis using activated protein c
12/19/2010CA2669877A1 Benzofuran-3-yl-(indol-3-yl)maleimides as potent gsk3 inhibitors
12/19/2010CA2669717A1 Formula and method for treating water in fish tanks
12/16/2010WO2010144909A1 Fused heterocyclic compounds and their uses
12/16/2010WO2010144865A2 Methods for treating gastrointestinal disorders
12/16/2010WO2010144827A1 Improved synthesis of picoplatin
12/16/2010WO2010144822A1 Compounds and methods for the modulation of sulfilimine bond formation
12/16/2010WO2010144817A1 Sublingual apomorphine
12/16/2010WO2010144759A1 Iminosugars and methods of treating bunyaviral and togaviral diseases
12/16/2010WO2010144742A2 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
12/16/2010WO2010144740A1 Improved lipid formulation
12/16/2010WO2010144712A1 Derivatives, reagents, and immunoassay for detecting levetiracetam
12/16/2010WO2010144686A1 Inhibition and dispersion of bacterial biofilms with benzimidazole derivatives
12/16/2010WO2010144685A1 Crystalline forms of febuxostat
12/16/2010WO2010144680A1 Benzimidazole derivatives useful as trpm8 channel modulators
12/16/2010WO2010144679A1 Benzimidazole derivatives useful as trpm8 channel modulators
12/16/2010WO2010144675A1 Polymorphs of bendamustine hcl and processes for preparation thereof
12/16/2010WO2010144664A1 Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
12/16/2010WO2010144647A1 Nicotinamide compounds useful as kinase modulators
12/16/2010WO2010144628A2 Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration
12/16/2010WO2010144586A1 Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
12/16/2010WO2010144571A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
12/16/2010WO2010144550A1 Triazine derivatives and their therapeutical applications
12/16/2010WO2010144535A1 Methods and compositions for the induction of hypothermia
12/16/2010WO2010144522A1 Ureidophenyl substituted triazine derivatives and their therapeutical applications
12/16/2010WO2010144518A1 Genotype specific methods for treating human subjects using 4- methylpyrazole
12/16/2010WO2010144513A1 Inhibitors of phosphatidylinositol 3-kinase
12/16/2010WO2010144499A2 Urea derivatives as kinase inhibitors
12/16/2010WO2010144498A2 Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate
12/16/2010WO2010144486A1 Dihydropyrrolonaphtyridinone compounds as inhibitors of jak
12/16/2010WO2010144477A2 Sulfonylurea modulators of endothelin receptor
12/16/2010WO2010144468A1 2- ( lh-pyrazol-4 -ylamino ) -pyrimidine as kinase inhibitors
12/16/2010WO2010144464A2 Solid dispersions containing an apoptosis-promoting agent
12/16/2010WO2010144446A1 (s) -2-benzyl-3- ( (3r, 4r) -4- (3 -carbamo ylphenyl) -3, 4-dimethylpiperidinyl) propanoic acid and salt therof as antagonists of the opioid receptors
12/16/2010WO2010144434A1 Derivatives of mefloquine and associated methods for making and using
12/16/2010WO2010144423A1 Styryl-triazine derivatives and their therapeutical applications
12/16/2010WO2010144416A1 SUBSTITUTED PYRAZOLO [1,5-a] PYRIDINE COMPOUNDS HAVING MULTI-TARGET ACTIVITY
12/16/2010WO2010144404A1 Pyridil-triazine inhibitors of hedgehog signaling
12/16/2010WO2010144403A1 Compositions and methods for treating pancreatic cancer
12/16/2010WO2010144394A1 Benzyl substituted triazine derivatives and their therapeutical applications
12/16/2010WO2010144371A1 Alkanoylamino benzamide aniline hdac inihibitor compounds
12/16/2010WO2010144359A1 Triazine derivatives and their therapeutical applications
12/16/2010WO2010144345A1 Triazine derivatives and their therapeutical applications
12/16/2010WO2010144338A1 Triazine derivatives and their therapeutical applications
12/16/2010WO2010144205A1 A most significant bits analog to digital converter, and an analog to digital converter including a most significant bits analog to digital converter
12/16/2010WO2010144140A2 Egfr and par2 regulation of intestinal permeability
12/16/2010WO2010144102A1 Pentafluorosulfanyl analogs of mefloquine
12/16/2010WO2010144066A1 Method for the preparation of ezetimib nanocrystals
12/16/2010WO2010144055A1 Novel compounds and uses thereof
12/16/2010WO2010144044A1 Use of a composition for the treatment of mucositis
12/16/2010WO2010144043A1 A novel 4-methylbenzenesulphonate salt and a process for preparing a pharmaceutical composition comprising the salt
12/16/2010WO2010143990A1 Pharmaceutical composition for use in medical and veterinary ophthalmology
12/16/2010WO2010143986A1 Combined therapy of colorectal carcinoma
12/16/2010WO2010143977A1 Copepod oil composition, formulations comprising the oil composition, and the use thereof to reduce accumulation of visceral fat, improve glucose tolerance, and prevent or treat obesity related diseases and disorders
12/16/2010WO2010143961A1 Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
12/16/2010WO2010143940A1 Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
12/16/2010WO2010143936A1 Composition and method for improving vascular health
12/16/2010WO2010143919A2 Method and composition for preventing or treating il-6-mediated diseases or rhinovirus infections
12/16/2010WO2010143825A2 Anti-arthritic agent using cyathula officinalis
12/16/2010WO2010143803A2 New nicotinamide derivatives with anti-androgen effects, processes of preparing, and antiandrogens comprising the same
12/16/2010WO2010143733A1 Novel fused cyclic compound and use thereof
12/16/2010WO2010143719A1 Alkaline decomposition product of hop extract and use thereof
12/16/2010WO2010143714A1 Aptamer for chymase, and use thereof
12/16/2010WO2010143664A1 Tetracyclic compound
12/16/2010WO2010143661A1 Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity
12/16/2010WO2010143627A1 Coccidiosis control agent and feed containing same
12/16/2010WO2010143582A1 Phenylcyclopropylamine derivatives and lsd1 inhibitors
12/16/2010WO2010143202A1 Pharmaceutical composition
12/16/2010WO2010143193A1 Targeted liposomes comprising n-containing bisphosphonates and uses thereof
12/16/2010WO2010143188A2 Halogenated aliphatic carboxylic acids, oligomers and/or polymers thereof and their use in devitalizing external and internal neoplasms
12/16/2010WO2010143186A1 Otic foam formulations
12/16/2010WO2010143170A2 Compounds useful for treating premature aging and in particular progeria
12/16/2010WO2010143169A2 Compounds useful for treating aids
12/16/2010WO2010143168A2 Compounds useful for treating cancer
12/16/2010WO2010143158A1 Oxazole and thiazole derivatives as alx receptor agonists
12/16/2010WO2010143116A1 Fluorinated aminotriazole derivatives
12/16/2010WO2010143101A1 Use of 1,25-dihydroxyvitamine d3 glycoside in lactating animals.
12/16/2010WO2010143062A1 Compositions and methods for prevention and treatment of coronary heart diseases
12/16/2010WO2010143058A1 Compositions and methods for the prevention and treatment of heart failure
12/16/2010WO2010143053A1 Methods and compositions for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome and related disorders
1 ... 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 ... 7860